glp 1 weight loss clinical trials Obesity Popular Weight-Loss Drug Found To

In a multicenter, randomized, placebo-controlled dose-finding trial, cagrilintide at doses ranging from 0.3 to 4.5 mg weekly produced dose-dependent weight reductions, with the 4.5 mg dose achieving approximately 10.8% weight loss at 26 weeks compared to 3.0% with placebo

Please note we do take weekend off but may occasionally respond on Saturdays and Sundays

How quickly can I get started

Education included target blood sugar range of 70-180 mg/dL, use of trend arrows, intervention for alerts (high alert set at 300 mg/dL, low alert set at 70 mg/dL) and education on Dexcom app

Tirzepatide and Semaglutide GLP-1 are both effective for weight management but differ in their mechanisms

We are excited to support you on your journey to self-enhancement